Catalyst Capital Advisors LLC

SEC CIK: 0001549275
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Catalyst Capital Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q2 2026): 50
Value: $15.1K
% of portfolio: <0.1%
Quarters held: 3; Since Q2 2025

Holdings of ALNY by Catalyst Capital Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	50	$15.1K	<0.1%	+11+28.2%	Added	Holders
Q1 2026	39	$12.9K	<0.1%	+39	New	Holders
Q3 2025	0	$0	0.0%	−453−100.0%	Sold out	Holders
Q2 2025	453	$147.7K	<0.1%	+453	New	Holders